Kintara Therapeutics, Inc.
KTRA
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.20% | 44.33% | 43.86% | 38.87% | 35.36% |
| Total Depreciation and Amortization | -8.33% | -11.67% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.77% | -43.30% | 33.77% | 152.96% | 117.23% |
| Change in Net Operating Assets | 113.26% | 101.99% | 114.45% | 162.56% | -3,889.09% |
| Cash from Operations | 39.52% | 52.82% | 63.89% | 68.59% | 41.82% |
| Capital Expenditure | 91.38% | 91.38% | 91.38% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 91.38% | 91.38% | 91.38% | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 442.08% | 7.88% | -73.34% | -99.56% | -91.06% |
| Repurchase of Common Stock | -- | -- | -- | 71.60% | 71.60% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 25.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 470.73% | 7.98% | -73.71% | -100.58% | -91.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 132.93% | 157.06% | 54.12% | 43.94% | -924.22% |
